|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-6-27
|
|
pubmed:abstractText |
Ascorbic acid supplementation has been recommended to circumvent resistance to erythropoietin, which sometimes occurs in iron-overloaded uremic patients. In considering the pro-oxidant effect of ascorbic acid, the authors hypothesize that adjuvant therapy with larger doses of ascorbic acid in hemodialysis patients with iron overload may raise the risk of increasing free radical generation. The oxidative stress of intravenous ascorbic acid supplementation in hemodialysis patients was evaluated in this study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2,2-diphenyl-1-picrylhydrazyl,
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/Ascorbic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Ferritins,
http://linkedlifedata.com/resource/pubmed/chemical/Free Radical Scavengers,
http://linkedlifedata.com/resource/pubmed/chemical/Free Radicals,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrazines,
http://linkedlifedata.com/resource/pubmed/chemical/Iron,
http://linkedlifedata.com/resource/pubmed/chemical/Picrates
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1523-6838
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
158-66
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12830468-Aged,
pubmed-meshheading:12830468-Antioxidants,
pubmed-meshheading:12830468-Ascorbic Acid,
pubmed-meshheading:12830468-Biphenyl Compounds,
pubmed-meshheading:12830468-Female,
pubmed-meshheading:12830468-Ferritins,
pubmed-meshheading:12830468-Free Radical Scavengers,
pubmed-meshheading:12830468-Free Radicals,
pubmed-meshheading:12830468-Humans,
pubmed-meshheading:12830468-Hydrazines,
pubmed-meshheading:12830468-Injections, Intravenous,
pubmed-meshheading:12830468-Iron,
pubmed-meshheading:12830468-Iron Overload,
pubmed-meshheading:12830468-Kidney Failure, Chronic,
pubmed-meshheading:12830468-Luminescent Measurements,
pubmed-meshheading:12830468-Male,
pubmed-meshheading:12830468-Middle Aged,
pubmed-meshheading:12830468-Oxidative Stress,
pubmed-meshheading:12830468-Picrates,
pubmed-meshheading:12830468-Renal Dialysis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters: influence of serum ferritin levels.
|
|
pubmed:affiliation |
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, ROC, China.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
In Vitro,
Controlled Clinical Trial
|
